StonvexLoading…
StonvexStonvexStonvexCore line items from SRE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.43B | $12.42B | $9.14B | $6.38B |
Operating Income | $996.00M | $1.79B | $1.55B | $1.26B |
Net Income | $1.04B | $1.84B | $1.49B | $1.39B |
EPS (Diluted) | $1.58 | $2.75 | $2.21 | $2.09 |
Total Assets | $113.52B | $110.88B | $106.92B | $99.91B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $794.00M | $29.00M | $5.00M | $155.00M |
Free Cash Flow OCF − CapEx | $-652.00M | $-6.05B | $-3.83B | $-2.37B |
Shares Outstanding | 653.34M | 652.73M | 652.53M | 652.25M |